Hello, everyone. Nice to see you again. We hope the weekend was refreshing and restful. Now, of course, the time has come to resume the routine as those meetings and deadlines await. So please join us as we reach for the mandatory cups of stimulation (yes, we are two-fisted drinkers here at the Pharmalot corporate campus) and scan the news of the world. Have a good day and stay in touch...
Sanofi Begins Hostile Bid For Genzyme (Associated Press)
Reata Pharmaceuticals Adds Jobs After Abbott Deal (Dallas Business Journal)
J&J Warns Concerta Sales Reps About Layoffs (The Wall Street Journal)
Will Lilly Bid For MannKind? (The Indianapolis Star)
Sihuan Pharma Sets $700M IPO (Reuters)
South Africa Researches Plant That Lifts Moods (Associated Press)
Antipsychotics, Illegal Marketing And Lawsuits (The New York Times)
Glaxo Cuts Prices In Indonesia (The Telegraph)
Panel Rules Painkiller Ads Were Misleading (New Zealand Herald)
J&J And Galapagos Ink Cancer Research Deal (PharmaTimes)
Mail-Order Pharmacy Gets Tax Breaks From Kentucky (Louisville Courier-Journal)
1 Comment
"Good WED afternoon!!!" No one will probably ever read this but YOU WERE MISSED!
Turns out it was only 2 days but it felt like a week!